Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
For the nine months, net income was ARS 717.86 million compared to net loss of ARS 192.53 million a year ago. Basic earnings per share from continuing operations was ARS 8.89 compared to basic loss per share from continuing operations of ARS 2.38 a year ago. Diluted earnings per share from continuing operations was ARS 8.89 compared to diluted loss per share from continuing operations of ARS 2.38 a year ago.